Literature DB >> 3772421

The concept of an overview of cancer clinical trials with special emphasis on early breast cancer.

R D Gelber, A Goldhirsch.   

Abstract

Overviews are valuable investigations that require international cooperation, and can provide a useful summary of available information on a current therapeutic issue. Combining results of trials in early breast cancer is an appropriate example of such procedures. However, the advantage of bringing a large amount of information together might be overcome by the disadvantages of improper conduct and overinterpretation of the overview findings. A prospective protocol must be prepared and followed. The results must be presented in sufficient detail to allow independent conclusions to be reached. The influence of strict application of the arithmetic construct must be recognized when determining whether the conclusions about the impact of separate components of treatment are appropriate. Most importantly, the transition from scientific inquiry to the application of treatment recommendations for individual patients must still be made very cautiously. We stress the importance of the results from individual, well-conducted clinical trials for providing the critical information for guiding the choice of treatment for patients outside of trials.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3772421     DOI: 10.1200/JCO.1986.4.11.1696

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  7 in total

1.  Meta-analyses in cancer clinical trials: principles and pitfalls.

Authors:  J R Benson; K Saeb-Parsy
Journal:  World J Surg       Date:  2006-07       Impact factor: 3.352

2.  Meta-analysis of the effectiveness of physical activity for the prevention of bone loss in postmenopausal women.

Authors:  A Bérard; G Bravo; P Gauthier
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

Review 3.  Adjuvant systemic therapy: state of the art, 1989.

Authors:  I C Henderson
Journal:  Breast Cancer Res Treat       Date:  1989-10       Impact factor: 4.872

Review 4.  Adjuvant chemotherapy for early breast cancer.

Authors:  I C Henderson
Journal:  Br J Cancer       Date:  1990-05       Impact factor: 7.640

Review 5.  The basis for current treatment recommendations for malignant gliomas.

Authors:  H A Fine
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

6.  Should women with node-negative breast cancer receive adjuvant chemotherapy?--Insights from a decision analysis model.

Authors:  B E Hillner; T J Smith
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

7.  Statistical issues in carcinogenic risk assessment.

Authors:  H E Rockette
Journal:  Environ Health Perspect       Date:  1991-01       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.